Editas Medicine (EDIT) Stock Price
$2.69 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Editas Medicine, AI stock picks, stock alerts and much more.
EDIT AI Stock Analysis
AI stock analysis for EDIT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Editas Medicine (EDIT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Editas Medicine (EDIT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Editas Medicine (EDIT), currently trading at $2.69, will... Sign up to access price prediction.
About EDIT
-
Editas Medicine, Inc.
-
Symbol
EDIT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
241.9M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
EDIT Alternative Data
Web Traffic
Editas Medicine receives an estimated 17334 monthly visitors to editasmedicine.com, which is up by 37.2% over the last month.
-
Web Traffic
17334
-
Change from Previous Month
37.2%
-
3 Month Change
18.4%
-
YoY Change
18.4%
LinkedIn Followers
49,352 are following Editas Medicine on LinkedIn, up by 0.4% over the last month.
-
LinkedIn Followers
49352
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Job Postings
Editas Medicine currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Editas Medicine has 224 employees, down by -3.9% over the last month.
-
LinkedIn Employees
224
-
Daily Change
0%
-
1 Month Change
3.9%
-
3 Month Change
13.2%
-
YoY Change
13.2%
Reddit Mentions
Editas Medicine has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Editas Medicine is 49 out of 100 (neutral).
-
Business Outlook
49
-
Change from Previous Month
0%
-
3 Month Change
18.3%
-
YoY Change
18.3%
News Mentions
Editas Medicine was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
EDIT Financials
EDIT Key Metrics
-
Total Revenue
$30.6M
-
Net Income
-$45.4M
-
Earnings per Share
-$0.55
-
Free cash flow
-$51.3M
-
EBITDA
-$33M
-
EBITDA Ratio
-1.07764
-
Total Assets
$341.6M
EDIT 2-year Revenue & Income
EDIT 2-year Free Cash Flow
EDIT Technicals
EDIT SMA
EDIT RSI
FAQ
What's the current price of Editas Medicine (EDIT) Stock?
The price of an Editas Medicine (EDIT) share is $2.69.
What's the market cap of Editas Medicine?
The current market cap of Editas Medicine is 241.9M.
What are some stocks similar to Editas Medicine (EDIT) that investors often compare it to?
Editas Medicine (EDIT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Editas Medicine's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Editas Medicine's stock price to be around $2.68 in 2026. Starting from the current price of $2.69, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Editas Medicine (EDIT) Stock?
Editas Medicine stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Editas Medicine shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.